Donald H. Picker

Donald H. Picker discloses dealings in Moleculin Biotech, Inc. to SEC (Form 4). Over a trading history stretching from 20 June 2023 to 3 August 2026, the count stands at 13 filings.

Purchases make up the whole of the open-market record (1 purchase). The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 6 share grants and 6 option exercises. So far in 2026, the count stands at 1 purchase and no sales.

The latest filing, published on 5 August 2026, reports an open-market purchase in Moleculin Biotech, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.